📰 Positive Node News
Positive Node News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Positive Node. Real-time updates on events, politics, business and more.
December 7, 2022
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations...
December 7, 2022
New independent clinical evidence from the pivotal TAILORx and RxPONDER trials support the role of the Oncotype DX Breast Recurrence Score test, the only genomic test to predict chemotherapy
December 6, 2022
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that new data presentations...
February 1, 2022
Clarkesworld Magazine Science Fiction and Fantasy. This page: Babirusa by Arula Ratnakar
December 2, 2021
In the study, postmenopausal women with 1 to 3 positive nodes and Recurrence Score® results of 0 to 25 showed no benefit from chemotherapy after a median of five years of follow-up, meaning they can potentially avoid negative side effects of the treatment. - Click here if this is your press release! - eTurboNews | Trends | Travel News
December 2, 2021
- RxPONDER, an independent study led by SWOG Cancer Research Network, demonstrates that guiding treatment with Oncotype DX test can spare chemotherapy use in majority of postmenopausal women -